Details of the Drug

General Information of Drug (ID: DMGUC9T)

Drug Name
HEV-239
Synonyms Hecolin; Bacterially-expressed hepatitis E vaccine, Xiamen Innovax Biotech; Hepatitis E vaccine (recombinant), Xiamen Innovax Biotech; Hepatitis E vaccine (alum-adjuvanted), Xiamen Innovax Biotech
Indication
Disease Entry ICD 11 Status REF
Hepatitis E virus infection 1E50.4 Approved [1]
Drug Type
Vaccine
Cross-matching ID
TTD ID
D0D6NQ

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Cell mediated immunity response (CMIR) TT3J5ZI NOUNIPROTAC Not Available [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT02189603) Phase Clinical Trial of Recombinant Hepatitis E Vaccine ecolin . U.S. National Institutes of Health.
2 The development of a recombinant hepatitis E vaccine HEV 239. Hum Vaccin Immunother. 2015;11(4):908-14.